Owonikoko, T. K., Papadopoulos, K. P., Gil-Martin, M., Moreno, V., Salama, A. K., Calvo, E., Safran, H., González-Martín, A., Aljumaily, R., Mahadevan, D., Niu, J., Kal Mohan, K., Li, J., Stankevich, E., Mathias, M., Lowy, I., Fury, M. G., & Babiker, H. M. (n.d.). 1292PPhase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-up efficacy and safety data. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095502419.0x000033